Agilent Technologies management check
A · Health Care · Life Sciences Tools & Services · CEO Padraig Mcdonnell
Filings as of
Closest peers in Life Sciences Tools & Services
- 101WATWaters Corporation76
- 108MTDMettler Toledo76
- 151DHRDanaher Corporation72
- 168IQVIQVIA71
- 307TMOThermo Fisher Scientific61
- 375CRLCharles River Laboratories56
- 386AAgilent Technologies55
- 443ILMNIllumina, Inc.47
- 453TECHBio-Techne45
The seven checks
- FlagTrailed its chosen peers
Have owners done well?
What $100 became since fiscal 2021
2130thDetail
$100 invested at the start of fiscal 2021 grew to $148, against $194 for the peer group the company picked itself.
- GoodPay rose and fell with returns
Does pay follow performance?
Pay actually paid $100 value, each on its own scale
9068thDetail
Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.80 with shareholder return. 1 means pay moved in step; below 0, the opposite way.
- Good0.8% of net income
What does the CEO cost owners?
$12.8m pay · $1.6bn net income, FY2025
5858thDetail
$12.8m of reported pay in fiscal 2025, against $1.6bn of net income.
- WatchCEO stake ≈ 0.9 years of pay
Do they own the stock?
65,566 shares ≈ $11.4m
6 mo: ▲ $0 bought · ▼ $313k sold
3232ndDetail
The CEO holds 65,566 shares, directly or through trusts (unvested awards not counted): about 0.9 years of pay. Light activity: no buys, $313k sold in six months.
- GoodShare count shrinking
Are owners being diluted?
Diluted shares −1.9% a year; flagged above +2%
Stock pay 1.8% of revenue
7365thDetail
Diluted shares changed -1.9% a year over the last three fiscal years. Stock-based pay was 1.8% of revenue in the latest year.
- Flag2 CEOs in the pay table
Is leadership stable?
15 filings under 8-K 5.02 in 3 years
CEOs: Mr. McMullen, Mr. McDonnell
107thDetail
CEOs in the pay table: Mr. McMullen, Mr. McDonnell. 15 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- GoodNo red flags on file
Are the books clean?
Since 2021
- 0Restated
- 0Auditor changes
- 0Late filings
- 010-K amended
100100thDetail
No restatements, auditor changes or late filings since 2021.
Reading the scores
Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.
Hover a chart for its figures. Detail has the full reading.
Pay versus performance
From the proxy statement filed February 6, 2026.
Pay tied most to AdjustedEPS
Other key measuresAdjusted Operating MarginAdjusted Earnings Per Share (EPS)Total Shareholder Return (TSR)Adjusted Revenue
Show the figures
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2025 | Mr. McDonnell | $12.8m | $14.6m | $3.8m | $148 | $194 | $1.6bn |
| 2024 | Mr. McDonnell, Mr. McMullen | $16.6m | $21.2m | $5.9m | $131 | $174 | $1.5bn |
| 2023 | Mr. McMullen | $16.0m | $1.0m | $3.7m | $103 | $134 | $1.2bn |
| 2022 | Mr. McMullen | $16.6m | $10.5m | $4.2m | $137 | $130 | $1.3bn |
| 2021 | Mr. McMullen | $16.0m | $31.8m | $3.8m | $155 | $140 | $1.2bn |
Insiders and the CEO's stakeQuiet
- President and CEO
- Padraig Mcdonnell
- Shares held
- 65,566
- At that filing's price
- ≈ $11.4m
- Latest Form 4
- Nov 13, 2026
Light activity: no buys, $313k sold in six months.
Open-market trades by officers and directors since May 21, 2026.
- SoldMikael DolstenDirector$313kSep 4, 2026
Leadership and governance on file
All 19 filings
- Sep 8, 2026Leadership change8-K 5.02
- May 27, 2026Leadership change8-K 5.02
- May 4, 2026Leadership change8-K 5.02
- Apr 6, 2026Leadership change8-K/A 5.02
- Mar 6, 2026Leadership change8-K 5.02
- Oct 27, 2025Leadership change8-K 5.02
- Aug 8, 2025Leadership change8-K/A 5.02
- Jul 15, 2025Leadership change8-K 5.02
- May 21, 2025Leadership change8-K 5.02
- May 2, 2025Leadership change8-K 5.02
- Apr 2, 2025Leadership change8-K 5.02
- May 24, 2024Leadership change8-K/A 5.02
- May 24, 2024Leadership change8-K 5.02
- May 1, 2024Leadership change8-K 5.02
- Feb 21, 2024Leadership change8-K 5.02
- Nov 1, 2023Leadership change8-K 5.02
- Sep 5, 2023Leadership change8-K 5.02
- Dec 22, 2021Leadership change8-K 5.02
- Nov 19, 2021Leadership change8-K 5.02
Latest shareholder vote results: Mar 20, 2026, including the say-on-pay vote.
Where the money went
2021–2025: $5.4bn returned to owners in buybacks and dividends, 86% of net income, and $603.0m of pay in stock.
Show the figures
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $6.3bn | $6.8bn | $6.8bn | $6.5bn | $6.9bn |
| Net income | $1.2bn | $1.3bn | $1.2bn | $1.3bn | $1.3bn |
| Stock-based pay | $110.0m | $125.0m | $111.0m | $129.0m | $128.0m |
| Buybacks | $788.0m | $1.1bn | $575.0m | $1.1bn | $425.0m |
| Dividends | $236.0m | $250.0m | $265.0m | $274.0m | $282.0m |
| Diluted shares | 307m | 300m | 296m | 291m | 285m |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.